Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread - PubMed (original) (raw)
Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread
R A Barry et al. Infect Immun. 1992 Apr.
Abstract
Listeria monocytogenes strains previously generated by transposon mutagenesis were examined with respect to virulence and induction of protective immunity in BALB/c mice. The phenotypic defects observed in these mutant L. monocytogenes strains included decreased hemolysin (listeriolysin O [LLO]) production, phospholipase C activity, intracellular growth, and/or cell-to-cell spread in vitro. While 50% lethal dose determinations performed with these mutant strains indicated reduced virulence for BALB/c mice, sublethal infection with the majority of these mutant strains provided protection against a subsequent challenge with the fully virulent L. monocytogenes parent strain. In addition, in vitro infection of the J774 cell line with most of these mutant strains converted these phagocytic cells to targets of L. monocytogenes-immune cytotoxic cells. The exceptions to these findings were two LLO-negative, avirulent mutant strains which were unable to immunize mice against a secondary challenge with virulent L. monocytogenes. One of these mutants contained a transposon insertion within the structural gene for LLO, and the other contained a transposon insertion in the structural gene for the transcriptional activator of the LLO gene. These two LLO-negative mutant strains also were unable to escape phagolysosomes in infected J774 cells and could not transform these phagocytic cells into targets of L. monocytogenes-immune cytotoxic cells. These findings confirm the importance of LLO in the induction of antilisterial immunity and suggest that a cytoplasmic localization of these pathogenic bacteria is required for the development of protective immunity.
Similar articles
- Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants.
Bouwer HG, Gibbins BL, Jones S, Hinrichs DJ. Bouwer HG, et al. Infect Immun. 1994 Mar;62(3):1039-45. doi: 10.1128/iai.62.3.1039-1045.1994. Infect Immun. 1994. PMID: 7509313 Free PMC article. - Stress-induced ClpP serine protease of Listeria monocytogenes is essential for induction of listeriolysin O-dependent protective immunity.
Gaillot O, Bregenholt S, Jaubert F, Di Santo JP, Berche P. Gaillot O, et al. Infect Immun. 2001 Aug;69(8):4938-43. doi: 10.1128/IAI.69.8.4938-4943.2001. Infect Immun. 2001. PMID: 11447171 Free PMC article. - Multifaceted activity of listeriolysin O, the cholesterol-dependent cytolysin of Listeria monocytogenes.
Seveau S. Seveau S. Subcell Biochem. 2014;80:161-95. doi: 10.1007/978-94-017-8881-6_9. Subcell Biochem. 2014. PMID: 24798012 Free PMC article. Review. - [Immunity in listeriosis].
Sereda AD, Kotliarov VM, Vorob'ev AA, Bakulov IA. Sereda AD, et al. Zh Mikrobiol Epidemiol Immunobiol. 2000 Sep-Oct;(5):98-102. Zh Mikrobiol Epidemiol Immunobiol. 2000. PMID: 11220980 Review. Russian.
Cited by
- RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids.
Abdullah Z, Schlee M, Roth S, Mraheil MA, Barchet W, Böttcher J, Hain T, Geiger S, Hayakawa Y, Fritz JH, Civril F, Hopfner KP, Kurts C, Ruland J, Hartmann G, Chakraborty T, Knolle PA. Abdullah Z, et al. EMBO J. 2012 Nov 5;31(21):4153-64. doi: 10.1038/emboj.2012.274. Epub 2012 Oct 12. EMBO J. 2012. PMID: 23064150 Free PMC article. - The secRNome of Listeria monocytogenes Harbors Small Noncoding RNAs That Are Potent Inducers of Beta Interferon.
Frantz R, Teubner L, Schultze T, La Pietra L, Müller C, Gwozdzinski K, Pillich H, Hain T, Weber-Gerlach M, Panagiotidis GD, Mostafa A, Weber F, Rohde M, Pleschka S, Chakraborty T, Abu Mraheil M. Frantz R, et al. mBio. 2019 Oct 8;10(5):e01223-19. doi: 10.1128/mBio.01223-19. mBio. 2019. PMID: 31594810 Free PMC article. - Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.
Hannan R, Zhang H, Wallecha A, Singh R, Liu L, Cohen P, Alfieri A, Rothman J, Guha C. Hannan R, et al. Cancer Immunol Immunother. 2012 Dec;61(12):2227-38. doi: 10.1007/s00262-012-1257-x. Epub 2012 May 27. Cancer Immunol Immunother. 2012. PMID: 22644735 Free PMC article. - Protective immunity to Listeria monocytogenes infection mediated by recombinant Listeria innocua harboring the VGC locus.
Mohamed W, Sethi S, Tchatalbachev S, Darji A, Chakraborty T. Mohamed W, et al. PLoS One. 2012;7(4):e35503. doi: 10.1371/journal.pone.0035503. Epub 2012 Apr 19. PLoS One. 2012. PMID: 22536395 Free PMC article. - Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation.
Angelakopoulos H, Loock K, Sisul DM, Jensen ER, Miller JF, Hohmann EL. Angelakopoulos H, et al. Infect Immun. 2002 Jul;70(7):3592-601. doi: 10.1128/IAI.70.7.3592-3601.2002. Infect Immun. 2002. PMID: 12065500 Free PMC article.
References
- Infect Immun. 1990 Apr;58(4):1048-58 - PubMed
- Infect Immun. 1990 Mar;58(3):654-8 - PubMed
- J Immunol. 1990 Dec 1;145(11):3540-6 - PubMed
- Clin Invest Med. 1984;7(4):303-9 - PubMed
- Rev Infect Dis. 1981 Nov-Dec;3(6):1221-50 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources